This TR focuses on the development of a risk-based control strategy adapted to cell-based therapy that can mitigate the risk of generating a product of poor quality.
Available to download. Prior to purchase please view the download instructions and Terms of Usage.
Format: PDF (1 file 3.45 MB)
Click here to order paper ship version (Item no. 01081).
*To purchase licensing, please contact PDA at [email protected].
Table of Contents:
Click here to download >>> Detailed Table of Contents
- Glossary and Abbreviations
- Product Profile
- Critical Quality Attributes
- Critical Process Parameters
- Critical Material Attributes
- Control Strategy
- Lifecycle Management
Figures and Tables Index